Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer: A Prospective Analysis of the EPIC Study

Abstract

Existing epidemiological evidence regarding the potential role of (poly)phenol intake in prostate cancer (PCa) risk is scarce and, in the case of flavonoids, it has been suggested that their intake may increase PCa risk. We investigated the associations between the intake of the total and individual classes and subclasses of (poly)phenols and the risk of PCa, including clinically relevant subtypes. The European Prospective Investigation into Cancer and Nutrition (EPIC) cohort included 131,425 adult men from seven European countries. (Poly)phenol intake at baseline was assessed by combining validated center/country-specific dietary questionnaires and the Phenol-Explorer database. Multivariable-adjusted Cox proportional hazards models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CI). In total, 6939 incident PCa cases (including 3501 low-grade and 710 high-grade, 2446 localized and 1268 advanced, and 914 fatal Pca cases) were identified during a mean follow-up of 14 years. No associations were observed between the total intake of (poly)phenols and the risk of PCa, either overall (HRlog2 = 0.99, 95% CI 0.94–1.04) or according to PCa subtype. Null associations were also found between all classes (phenolic acids, flavonoids, lignans, and stilbenes) and subclasses of (poly)phenol intake and the risk of PCa, overall and according to PCa subtype. The results of the current large prospective cohort study do not support any association between (poly)phenol intake and PCa incidence.

Natural products targeting the MAPK-signaling pathway in cancer: overview

“…Phenolic compounds are plant secondary metabolites that are widely found in nature. Phenolic compounds are structurally diverse and have antioxidant, anti-tumor, and antiviral effects (Almanza-Aguilera et al 2023 ; Huminiecki 2022 ; Sorrenti et al 2023 ). Phenolic compounds can regulate cancer cell apoptosis by modulating protein kinases in the MAPK-signaling pathway.…”

Functionalized magnetic nanoparticles for electrochemical magneto biosensing of PSMA cancer biomarker

“…Prostate cancer (PCa) is the second-most common malignancy in men, with about 1.414 million new cases and 375,304 deaths reported in 2020. 1 The only known risk factors for PCa are age, ethnicity, and family history, which make its etiology less obvious than that of other common cancers. 2 Furthermore, a number of germline genetic variables that may increase the incidence of malignancies, including PCa, have recently been found by genetic epidemiology research.…”